{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.3616.200.110.102.1017",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2022-07-13T01:02:20.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1017",
  "version": "20220713",
  "name": "Tocilizumab Administration",
  "status": "active",
  "date": "2022-07-13T01:02:20-04:00",
  "publisher": "Clinical Architecture",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "concept": [
          {
            "code": "J3262",
            "display": "Injection, tocilizumab, 1 mg"
          },
          {
            "code": "M0249",
            "display": "Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose"
          },
          {
            "code": "M0250",
            "display": "Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose"
          },
          {
            "code": "Q0249",
            "display": "Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:cc03138a-b614-4ddb-8997-a1f45c510112",
    "timestamp": "2022-09-28T05:54:04-04:00",
    "total": 4,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "J3262",
        "display": "Injection, tocilizumab, 1 mg"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "M0249",
        "display": "Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "M0250",
        "display": "Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "Q0249",
        "display": "Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg"
      }
    ]
  }
}